[go: up one dir, main page]

FR2905600B1 - Traitement des vertiges par l'acetyl-l-leucine. - Google Patents

Traitement des vertiges par l'acetyl-l-leucine.

Info

Publication number
FR2905600B1
FR2905600B1 FR0607992A FR0607992A FR2905600B1 FR 2905600 B1 FR2905600 B1 FR 2905600B1 FR 0607992 A FR0607992 A FR 0607992A FR 0607992 A FR0607992 A FR 0607992A FR 2905600 B1 FR2905600 B1 FR 2905600B1
Authority
FR
France
Prior art keywords
vertigs
leucine
acetyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0607992A
Other languages
English (en)
Other versions
FR2905600A1 (fr
Inventor
Pierre Fabre
Christophe Przybylski
Anne Sophie Saurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR0607992A priority Critical patent/FR2905600B1/fr
Priority to TW096134031A priority patent/TW200817030A/zh
Priority to US12/310,908 priority patent/US20090318555A1/en
Priority to EP07825741A priority patent/EP2068860A2/fr
Priority to CA002663206A priority patent/CA2663206A1/fr
Priority to PCT/IB2007/003644 priority patent/WO2008032222A2/fr
Priority to MX2009002725A priority patent/MX2009002725A/es
Priority to ARP070104058A priority patent/AR062784A1/es
Priority to AU2007297181A priority patent/AU2007297181B2/en
Priority to JP2009527922A priority patent/JP2010503658A/ja
Priority to NZ576150A priority patent/NZ576150A/en
Publication of FR2905600A1 publication Critical patent/FR2905600A1/fr
Priority to ZA200901452A priority patent/ZA200901452B/xx
Priority to FR0951944A priority patent/FR2943537B1/fr
Application granted granted Critical
Publication of FR2905600B1 publication Critical patent/FR2905600B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0607992A 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine. Expired - Fee Related FR2905600B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0607992A FR2905600B1 (fr) 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine.
TW096134031A TW200817030A (en) 2006-09-13 2007-09-12 Treatment of vertigo with acetyl-l-leucine
JP2009527922A JP2010503658A (ja) 2006-09-13 2007-09-13 アセチル−ｌ−ロイシンによるめまいの治療
CA002663206A CA2663206A1 (fr) 2006-09-13 2007-09-13 Traitement des vertiges avec de l'acetyl-l-leucine
PCT/IB2007/003644 WO2008032222A2 (fr) 2006-09-13 2007-09-13 Traitement des vertiges avec de l'acétyl-l-leucine
MX2009002725A MX2009002725A (es) 2006-09-13 2007-09-13 Tratamiento del vertigo con acetil-l-leucina.
US12/310,908 US20090318555A1 (en) 2006-09-13 2007-09-13 Treatment of Vertigo with Acetyl-L-Leucine
AU2007297181A AU2007297181B2 (en) 2006-09-13 2007-09-13 Treatment of vertigo with acetyl-L-leucine
EP07825741A EP2068860A2 (fr) 2006-09-13 2007-09-13 Traitement des vertiges avec de l'acétyl-l-leucine
NZ576150A NZ576150A (en) 2006-09-13 2007-09-13 Use of acetyl-L-leucine in the treatment of vestibular neuritis
ARP070104058A AR062784A1 (es) 2006-09-13 2007-09-13 Tratmiento de los vertigos con acetil -l- leucina
ZA200901452A ZA200901452B (en) 2006-09-13 2009-03-02 Treatment of vertigo with acetyl-L-leucine
FR0951944A FR2943537B1 (fr) 2006-09-13 2009-03-25 Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0607992A FR2905600B1 (fr) 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine.

Publications (2)

Publication Number Publication Date
FR2905600A1 FR2905600A1 (fr) 2008-03-14
FR2905600B1 true FR2905600B1 (fr) 2010-01-15

Family

ID=37709503

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0607992A Expired - Fee Related FR2905600B1 (fr) 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine.
FR0951944A Expired - Fee Related FR2943537B1 (fr) 2006-09-13 2009-03-25 Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR0951944A Expired - Fee Related FR2943537B1 (fr) 2006-09-13 2009-03-25 Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Country Status (12)

Country Link
US (1) US20090318555A1 (fr)
EP (1) EP2068860A2 (fr)
JP (1) JP2010503658A (fr)
AR (1) AR062784A1 (fr)
AU (1) AU2007297181B2 (fr)
CA (1) CA2663206A1 (fr)
FR (2) FR2905600B1 (fr)
MX (1) MX2009002725A (fr)
NZ (1) NZ576150A (fr)
TW (1) TW200817030A (fr)
WO (1) WO2008032222A2 (fr)
ZA (1) ZA200901452B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2010000251A1 (fr) * 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
KR102413754B1 (ko) * 2016-04-19 2022-06-27 인트라바이오 리미티드 이동성 및 인지 기능을 개선시키기 위한 아세틸-류신 또는 이의 약제학적으로 허용되는 염
PL3416631T3 (pl) 2016-08-11 2019-11-29 Intrabio Ltd Środki terapeutyczne do leczenia chorób neurodegeneracyjnych
MA55947A (fr) * 2016-08-11 2022-03-23 Intrabio Ltd Compositions pharmaceutiques et utilisations dirigées vers des troubles d'entreposage lysosomial
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
US12458614B2 (en) * 2017-10-18 2025-11-04 Intrabio Ltd Therapeutic agents for improved mobility and cognitive function and for treating neurodegenerative diseases and lysosomal storage disorders
IL321899A (en) * 2019-03-02 2025-09-01 Intrabio Ltd Leucine, acetyl leucine and related analogs for the treatment of disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2941924A (en) * 1956-03-30 1960-06-21 Rhone Poulenc Sa Monoethanolamine salt of alpha-(acetylamino)-isocaproic acid
GB798680A (en) * 1956-03-30 1958-07-23 Rhone Poulenc Sa Improvements in or relating to the preparation of pharmaceutical compositions

Also Published As

Publication number Publication date
TW200817030A (en) 2008-04-16
MX2009002725A (es) 2009-03-25
FR2943537B1 (fr) 2011-05-13
FR2943537A1 (fr) 2010-10-01
WO2008032222A2 (fr) 2008-03-20
CA2663206A1 (fr) 2008-03-20
WO2008032222A3 (fr) 2008-05-02
FR2905600A1 (fr) 2008-03-14
JP2010503658A (ja) 2010-02-04
AU2007297181B2 (en) 2013-10-17
AU2007297181A1 (en) 2008-03-20
NZ576150A (en) 2011-11-25
US20090318555A1 (en) 2009-12-24
EP2068860A2 (fr) 2009-06-17
ZA200901452B (en) 2010-04-28
AR062784A1 (es) 2008-12-03

Similar Documents

Publication Publication Date Title
FR20C1034I1 (fr) Traitement combiné de tumeurs exprimant la cd38
EP1996612A4 (fr) Compositions destinee au traitement des cancers
EP1957413A4 (fr) Traitement des eaux d'egout
EP2303184A4 (fr) Traitement d'association du glaucome
EP1898930A4 (fr) Traitement d'etats inflammatoires
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP1982660A4 (fr) Endoscope de traitement
EP1996182A4 (fr) Traitement anticancéreux utilisant des inhibiteurs de gamma-sécrétases
EP2034839A4 (fr) Traitement de maladies neurodégénératives par l'inhibition de hsp90
EP1744751A4 (fr) Traitement des synucleinopathies
LT2478907T (lt) Kompozicijos vėžiui gydyti
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
EP2338519A4 (fr) Agent de traitement d'une myélofibrose
EP2307035A4 (fr) Traitement de l'épilepsie
EP2023950A4 (fr) Traitement du cancer par l'urodilatine
EP2135858A4 (fr) Composition destinée à traiter des maladies infectieuses
ATE496924T1 (de) Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
EP1943972A4 (fr) Instrument pour traitement endoscopique
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine
EP2274245A4 (fr) Phytosystème destiné au traitement des eaux usées
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
EP2173364A4 (fr) Traitement ou prévention d'une infection par un rotavirus
EP1830847A4 (fr) Traitement anticancereux
FR2876047B1 (fr) Traitement de polluants par phytolixiviation
DE602006009764D1 (de) Terphenylderivate zur Alzheimerbehandlung

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150529